* Avanos Medical Inc AVNS.N reported quarterly adjusted
earnings
of 19 cents per share for the quarter ended in March, lower
than the same quarter last year, when the company reported EPS
of 27 cents. The mean expectation of three analysts for the
quarter was for earnings of 21 cents per share. Wall Street
expected results to range from 20 cents to 22 cents per share.
* Revenue fell 13.4% to $166.10 million from a year ago;
analysts
expected $162.90 million.
* Avanos Medical Inc's reported EPS for the quarter was a
loss
of 2 cents.
* Avanos Medical Inc shares had fallen by 1.0% this
quarter and
lost 12.1% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 19.2%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* Wall Street's median 12-month price target for Avanos
Medical
Inc is $23.50
This summary was machine generated from LSEG data May 3 at 08:15
a.m. UTC. All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 0.21 0.19 Missed
Dec. 31 2023 0.37 0.32 Missed
Sep. 30 2023 0.28 0.42 Beat
Jun. 30 2023 0.30 0.37 Beat